JT001 sodium

Overview

JT001 (NLRP3-IN-19) sodium is a potent, specific and orally active inhibitor of NLRP3 . JT001 sodium can inhibit NLRP3 inflammasome assembly, resulting in the inhibition of cytokine release and the prevention of pyroptosis . JT001 sodium can be used for the research of nonalcoholic steatohepatitis and liver fibrosis.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Depression | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Digestive System Inflammation | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > NOD-like Receptor (NLR)

Product Information

• Catalog No.: HY-156034A
• CAS No.: 2238820-09-0
• Molecular Formula: C19H22N4NaO4S
• Molecular Weight: 425.46
• Purity: 98.39%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Availability: In-stock

Source

Original product source